Supply Chain. 340B Issues. Genetically Targeted Therapies. PBM policy issues. H.R.5376 - Inflation Reduction Act of 2022 implementation. Most Favored Nation (MFN) policy.
Literal federal measure citations: H.R.5376
2026 · 2nd Quarter (Apr 1 - June 30)
NOVARTIS, INC.
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 17, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- NOVARTIS, INC.
- Filing UUID
- a77c1900-cf81-4f2c-b0e4-15cd9b5cca15
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Center for Medicare and Medicaid Innovation (CMMI) policy issues. Drug Pricing. General Medicare and Medicaid Issues. Implementation of Inflation Reduction Act of 2022. H.R.1672 - Maintaining Investments in New Innovation Act. S.3131 / H.R.5539 - ORPHAN Cures Act. S.832/H.R.1492: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025.
Literal federal measure citations: H.R.1672, S.3131, H.R.5539, S.832, H.R.1492
Tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.